Leen Kawas: A Pioneering Leader in Biopharmaceutical Industry
Leen Kawas is a prominent name in the biopharmaceutical industry, renowned for her leadership, vision, and dedication to improving healthcare outcomes. With a Ph.D. in Pharmacy and Pharmaceutical Sciences, Kawas is the CEO and President of M3 Biotechnology, a clinical-stage biopharmaceutical company that specializes in developing therapies for neurodegenerative diseases.
Before joining M3 Biotechnology, Kawas held several leadership positions at companies such as Amgen and Alnylam Pharmaceuticals, where she played a crucial role in advancing novel drug candidates and expanding the companies’ portfolios. She is also a member of the Board of Directors of the Biotechnology Innovation Organization (BIO), a prestigious global organization dedicated to advancing biotechnology to benefit society.
At M3 Biotechnology, Leen Kawas is leading the development of a first-in-class neuroprotective drug candidate called NOX-B11, which has the potential to halt the progression of Alzheimer’s disease and other neurodegenerative disorders. She has secured significant funding for the company, including a $16 million Series B funding round in 2019, which will help accelerate clinical trials and advance the company’s research.
Besides her work in the biopharmaceutical industry, Leen Kawas is a passionate advocate for diversity, equity, and inclusion. She believes in creating a more diverse and inclusive workforce and actively supports women’s leadership initiatives. In 2021, she was named a Champion of Change by the Healthcare Businesswomen’s Association (HBA) for her efforts to advance gender parity in the industry.
Under Leen Kawas’ leadership, M3 Biotechnology has emerged as a leading player in the biopharmaceutical industry, driven by a mission to improve patient outcomes and change the course of debilitating diseases. Her vision and dedication to innovation and diversity have earned her several accolades, and she continues to inspire the next generation of leaders in the industry.
Leen Kawas is a pioneering leader in the biopharmaceutical industry, known for her innovative ideas, dedication to improving healthcare outcomes, and advocacy for diversity and inclusion. Her work at M3 Biotechnology and other companies has made a significant impact on the industry and brought hope to millions of patients suffering from neurodegenerative diseases.
Leen Kawas is a prominent name in the biopharmaceutical industry, renowned for her leadership, vision, and dedication to improving healthcare outcomes. With a Ph.D. in Pharmacy and Pharmaceutical Sciences, Kawas is the CEO and President of M3 Biotechnology, a clinical-stage biopharmaceutical company that specializes in developing therapies for neurodegenerative diseases. Before joining M3 Biotechnology, Kawas…